ConductScience.org, home

Paper9102399

Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3).

Degerman E and 2 others. J Biol Chem, 1997. Cited by 363 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). Papers, record 9102399. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9102399

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3).
PubMed
Journal
J Biol Chem
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
363
iCite
Relative citation ratio, by iCite
8.71
iCite
Revised in PubMed
2021-02-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Degerman EE
2Belfrage PP
3Manganiello VCV C

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
3',5'-Cyclic-AMP PhosphodiesterasesMajor topic
Animals
Cyclic Nucleotide Phosphodiesterases, Type 3
Gene Expression Regulation, Enzymologic
Humans

Source PubMed

Cited by111

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 363 citations.

PMIDTitleJournalYearIn PapersSource
42,236,056Intercellular cyclic nucleotide dynamics mediate oocyte meiosis in mammalian preovulatory follicles.Curr Top Dev Biol2026https://conductscience.org/library/papers/42236056PubMed
42,047,795Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).J Mol Med (Berl)2026https://conductscience.org/library/papers/42047795PubMed
41,757,835In vitro maturation 2.0: a new era for an underdog in ART.JBRA Assist Reprod2026https://conductscience.org/library/papers/41757835PubMed
41,732,176Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential.Bone Rep2026https://conductscience.org/library/papers/41732176PubMed
41,227,315Cyclic Nucleotide Phosphodiesterase Families as Targets to Treat Pulmonary Arterial Hypertension: Beyond PDE5 Inhibitors?Cells2025https://conductscience.org/library/papers/41227315PubMed
41,150,877Schlafen 12 Modulation and Targeting in Acute Myeloid Leukemia.Cancer Res Commun2025https://conductscience.org/library/papers/41150877PubMed
40,100,370Cilostazol alleviates imatinib-induced myocardial injury in rats by modulating the TGF-β1/MAPK, SHC/Grb2/SOS signaling pathways and upregulating miRNA-195-5P.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40100370PubMed
39,572,771Integrated responses of the SIP syncytium generate a major motility pattern in the colon.J Physiol2024https://conductscience.org/library/papers/39572771PubMed
39,435,735Pde3a and Pde3b regulation of murine pulmonary artery smooth muscle cell growth and metabolism.Physiol Rep2024https://conductscience.org/library/papers/39435735PubMed
39,273,390Cyclic Adenosine Monophosphate Signaling in Chronic Kidney Disease: Molecular Targets and Therapeutic Potentials.Int J Mol Sci2024https://conductscience.org/library/papers/39273390PubMed
38,473,840The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis.Int J Mol Sci2024https://conductscience.org/library/papers/38473840PubMed
38,262,506The perspective of cAMP/cGMP signaling and cyclic nucleotide phosphodiesterases in aortic aneurysm and dissection.Vascul Pharmacol2024https://conductscience.org/library/papers/38262506PubMed
37,781,231A preliminary study of phosphodiesterases and adenylyl cyclase signaling pathway on red blood cell deformability of sickle cell patients.Front Physiol2023https://conductscience.org/library/papers/37781231PubMed
37,540,009Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans.Brain2023https://conductscience.org/library/papers/37540009PubMed
37,324,679A cAMP phosphodiesterase is essential for sclerotia formation and virulence in Sclerotinia sclerotiorum.Front Plant Sci2023https://conductscience.org/library/papers/37324679PubMed
37,165,086It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3.Commun Biol2023https://conductscience.org/library/papers/37165086PubMed
36,817,146Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba2.Front Pharmacol2023https://conductscience.org/library/papers/36817146PubMed
36,813,290Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.Eur Respir Rev2023https://conductscience.org/library/papers/36813290PubMed
36,268,188Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer's disease.Front Aging Neurosci2022https://conductscience.org/library/papers/36268188PubMed
36,015,172Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36015172PubMed

See all 111 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9102399

GET https://conductscience.org/api/papers/v1/9102399/cited_by?page=2